Literature DB >> 10962771

A comparison of four buprenorphine dosing regimens using open-dosing procedures: is twice-weekly dosing possible?

N M Petry1, W K Bickel, G J Badger.   

Abstract

AIMS: To compare opioid withdrawal symptoms during 24-, 48-, 72- and 96-hour buprenorphine dosing regimens and to evaluate subjects' preferences for these different dosing schedules.
SUBJECTS: Fourteen opioid-dependent subjects participated in this study. They received daily sublingual maintenance doses of 4 mg/70 kg (n = 4) or 8 mg/70 kg (n = 10) of buprenorphine. INTERVENTION: In the first study subjects received, in a random order, four dosing regimens for five repetitions of each: daily maintenance doses every 24 hours (4 or 8 mg/70 kg), double the daily maintenance dose every 48 hours (8 or 16 mg/70 kg), triple the daily maintenance dose every 72 hours (12 or 24 mg/70 kg), and quadruple the daily maintenance dose every 96 hours (16 or 32 mg/70 kg). Measures of subjective and observer opioid withdrawal symptoms were assessed prior to receipt of each dose. In a second study, subjects chose between the different dosing regimens.
FINDINGS: Some withdrawal ratings increased during the less frequent dosing schedules in the first study. In the second study, 46% of subjects preferred the quadruple-every-fourth-day dosing regimen over every other option, and only 14% preferred to be dosed daily.
CONCLUSIONS: These results suggest that some opioid-dependent outpatients are willing and able to endure the withdrawal symptoms associated with less than daily dosing, and a twice-weekly dosing regimen may be possible.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10962771     DOI: 10.1046/j.1360-0443.2000.95710698.x

Source DB:  PubMed          Journal:  Addiction        ISSN: 0965-2140            Impact factor:   6.526


  3 in total

Review 1.  The effectiveness of community maintenance with methadone or buprenorphine for treating opiate dependence.

Authors:  Steven Simoens; Catriona Matheson; Christine Bond; Karen Inkster; Anne Ludbrook
Journal:  Br J Gen Pract       Date:  2005-02       Impact factor: 5.386

Review 2.  Treatment of opioid-dependent pregnant women: clinical and research issues.

Authors:  Hendree E Jones; Peter R Martin; Sarah H Heil; Karol Kaltenbach; Peter Selby; Mara G Coyle; Susan M Stine; Kevin E O'Grady; Amelia M Arria; Gabriele Fischer
Journal:  J Subst Abuse Treat       Date:  2008-01-14

Review 3.  Practical considerations for the clinical use of buprenorphine.

Authors:  Hendree E Jones
Journal:  Sci Pract Perspect       Date:  2004-08
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.